| 0 |
INJECTION SITE PAIN |
805 |
| 1 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
49 |
| 2 |
INJECTION SITE ERYTHEMA |
48 |
| 3 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
47 |
| 4 |
DRUG DOSE OMISSION BY DEVICE |
43 |
| 5 |
INJECTION SITE SWELLING |
40 |
| 6 |
HEADACHE |
38 |
| 7 |
DEVICE MECHANICAL ISSUE |
36 |
| 8 |
NEEDLE ISSUE |
36 |
| 9 |
DEVICE DELIVERY SYSTEM ISSUE |
33 |
| 10 |
PATIENT-DEVICE INCOMPATIBILITY |
33 |
| 11 |
OFF LABEL USE |
32 |
| 12 |
DEVICE LEAKAGE |
28 |
| 13 |
INCORRECT DOSE ADMINISTERED |
27 |
| 14 |
INJECTION SITE MASS |
27 |
| 15 |
DEVICE ISSUE |
21 |
| 16 |
INJECTION SITE HAEMORRHAGE |
21 |
| 17 |
INJECTION SITE PRURITUS |
21 |
| 18 |
PRODUCT DOSE OMISSION ISSUE |
21 |
| 19 |
INJECTION SITE BRUISING |
19 |
| 20 |
PRODUCT COMMUNICATION ISSUE |
19 |
| 21 |
CRYING |
18 |
| 22 |
VOMITING |
18 |
| 23 |
DRUG INEFFECTIVE |
16 |
| 24 |
DEVICE DIFFICULT TO USE |
15 |
| 25 |
ANXIETY |
14 |
| 26 |
INJECTION SITE DISCOMFORT |
14 |
| 27 |
INJURY ASSOCIATED WITH DEVICE |
14 |
| 28 |
EXPOSURE VIA SKIN CONTACT |
13 |
| 29 |
LIPODYSTROPHY ACQUIRED |
13 |
| 30 |
PAIN |
13 |
| 31 |
PYREXIA |
13 |
| 32 |
WEIGHT INCREASED |
13 |
| 33 |
DEVICE BREAKAGE |
12 |
| 34 |
DIZZINESS |
12 |
| 35 |
FEAR OF INJECTION |
12 |
| 36 |
LACK OF INJECTION SITE ROTATION |
12 |
| 37 |
NAUSEA |
12 |
| 38 |
SEIZURE |
12 |
| 39 |
ACCIDENTAL EXPOSURE TO PRODUCT |
10 |
| 40 |
DEVICE DEFECTIVE |
10 |
| 41 |
INJECTION SITE DISCHARGE |
10 |
| 42 |
INJECTION SITE RASH |
10 |
| 43 |
PAIN IN EXTREMITY |
10 |
| 44 |
POOR QUALITY DEVICE USED |
10 |
| 45 |
RASH |
10 |
| 46 |
DEVICE PHYSICAL PROPERTY ISSUE |
9 |
| 47 |
FATIGUE |
9 |
| 48 |
SYNCOPE |
9 |
| 49 |
INJECTION SITE REACTION |
8 |
| 50 |
PRODUCT PRESCRIBING ERROR |
8 |
| 51 |
DEVICE USE ERROR |
7 |
| 52 |
ERYTHEMA |
7 |
| 53 |
PNEUMONIA |
7 |
| 54 |
PRODUCT CONTAMINATION |
7 |
| 55 |
PUNCTURE SITE HAEMORRHAGE |
7 |
| 56 |
ABDOMINAL PAIN |
6 |
| 57 |
ABDOMINAL PAIN UPPER |
6 |
| 58 |
ARTHRALGIA |
6 |
| 59 |
DEVICE MALFUNCTION |
6 |
| 60 |
DEVICE MATERIAL ISSUE |
6 |
| 61 |
HYPOGLYCAEMIA |
6 |
| 62 |
INTENTIONAL PRODUCT MISUSE |
6 |
| 63 |
URTICARIA |
6 |
| 64 |
ABNORMAL BEHAVIOUR |
5 |
| 65 |
DEVICE OCCLUSION |
5 |
| 66 |
DEVICE USE ISSUE |
5 |
| 67 |
DIARRHOEA |
5 |
| 68 |
EPIPHYSIOLYSIS |
5 |
| 69 |
FEELING ABNORMAL |
5 |
| 70 |
INFLUENZA |
5 |
| 71 |
INJECTION SITE ATROPHY |
5 |
| 72 |
INTRACRANIAL PRESSURE INCREASED |
5 |
| 73 |
MALAISE |
5 |
| 74 |
PAPILLOEDEMA |
5 |
| 75 |
PRURITUS |
5 |
| 76 |
SCREAMING |
5 |
| 77 |
UNDERDOSE |
5 |
| 78 |
AGGRESSION |
4 |
| 79 |
ASTHENIA |
4 |
| 80 |
CONDITION AGGRAVATED |
4 |
| 81 |
COUGH |
4 |
| 82 |
DEVICE DEPLOYMENT ISSUE |
4 |
| 83 |
DRUG HYPERSENSITIVITY |
4 |
| 84 |
DRY SKIN |
4 |
| 85 |
EPILEPSY |
4 |
| 86 |
HUNGER |
4 |
| 87 |
ILLNESS |
4 |
| 88 |
INCREASED APPETITE |
4 |
| 89 |
INJECTION SITE INDURATION |
4 |
| 90 |
INJECTION SITE INFLAMMATION |
4 |
| 91 |
INSOMNIA |
4 |
| 92 |
INSULIN-LIKE GROWTH FACTOR DECREASED |
4 |
| 93 |
MIGRAINE |
4 |
| 94 |
MOOD ALTERED |
4 |
| 95 |
NASAL CONGESTION |
4 |
| 96 |
OEDEMA PERIPHERAL |
4 |
| 97 |
PATIENT-DEVICE INTERACTION ISSUE |
4 |
| 98 |
POOR QUALITY PRODUCT ADMINISTERED |
4 |
| 99 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
4 |
| 100 |
PRODUCT ODOUR ABNORMAL |
4 |
| 101 |
SWELLING |
4 |
| 102 |
WEIGHT DECREASED |
4 |
| 103 |
ACCIDENTAL UNDERDOSE |
3 |
| 104 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
3 |
| 105 |
AGITATION |
3 |
| 106 |
DEPRESSED MOOD |
3 |
| 107 |
DYSGEUSIA |
3 |
| 108 |
EMOTIONAL DISORDER |
3 |
| 109 |
EOSINOPHIL COUNT INCREASED |
3 |
| 110 |
FLUID RETENTION |
3 |
| 111 |
GAIT DISTURBANCE |
3 |
| 112 |
GASTROENTERITIS VIRAL |
3 |
| 113 |
GROWTH RETARDATION |
3 |
| 114 |
HYPERSENSITIVITY |
3 |
| 115 |
INJECTION SITE URTICARIA |
3 |
| 116 |
INSULIN-LIKE GROWTH FACTOR INCREASED |
3 |
| 117 |
NASOPHARYNGITIS |
3 |
| 118 |
NEOPLASM MALIGNANT |
3 |
| 119 |
OEDEMA |
3 |
| 120 |
PANIC ATTACK |
3 |
| 121 |
PRODUCT PRESCRIBING ISSUE |
3 |
| 122 |
SCRATCH |
3 |
| 123 |
VIRAL INFECTION |
3 |
| 124 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
3 |
| 125 |
ADRENAL INSUFFICIENCY |
2 |
| 126 |
APPETITE DISORDER |
2 |
| 127 |
ASTHMA |
2 |
| 128 |
AUTISM SPECTRUM DISORDER |
2 |
| 129 |
BACK PAIN |
2 |
| 130 |
BLINDNESS |
2 |
| 131 |
BLOOD GROWTH HORMONE INCREASED |
2 |
| 132 |
BLOOD PROLACTIN INCREASED |
2 |
| 133 |
BRONCHITIS |
2 |
| 134 |
CHEST PAIN |
2 |
| 135 |
CLAVICLE FRACTURE |
2 |
| 136 |
CONSTIPATION |
2 |
| 137 |
CONTUSION |
2 |
| 138 |
CORTISOL INCREASED |
2 |
| 139 |
CUSHING^S SYNDROME |
2 |
| 140 |
DEAFNESS |
2 |
| 141 |
DEATH |
2 |
| 142 |
DECREASED APPETITE |
2 |
| 143 |
DEPRESSION |
2 |
| 144 |
DISEASE PROGRESSION |
2 |
| 145 |
DRUG INTOLERANCE |
2 |
| 146 |
DYSGRAPHIA |
2 |
| 147 |
DYSPHAGIA |
2 |
| 148 |
DYSPNOEA |
2 |
| 149 |
EAR INFECTION |
2 |
| 150 |
EPISTAXIS |
2 |
| 151 |
EXTRA DOSE ADMINISTERED |
2 |
| 152 |
FACIAL PARALYSIS |
2 |
| 153 |
GUILLAIN-BARRE SYNDROME |
2 |
| 154 |
HEART RATE INCREASED |
2 |
| 155 |
HOT FLUSH |
2 |
| 156 |
HYPERHIDROSIS |
2 |
| 157 |
HYPERTROPHY |
2 |
| 158 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
| 159 |
INFLUENZA LIKE ILLNESS |
2 |
| 160 |
INJECTION SITE HAEMATOMA |
2 |
| 161 |
INJECTION SITE HYPERSENSITIVITY |
2 |
| 162 |
INJECTION SITE HYPOAESTHESIA |
2 |
| 163 |
LOSS OF CONSCIOUSNESS |
2 |
| 164 |
MELANOCYTIC NAEVUS |
2 |
| 165 |
MENTAL DISORDER |
2 |
| 166 |
MIDDLE INSOMNIA |
2 |
| 167 |
NEGATIVE THOUGHTS |
2 |
| 168 |
NO ADVERSE EVENT |
2 |
| 169 |
OBSESSIVE-COMPULSIVE DISORDER |
2 |
| 170 |
OPTIC NEUROPATHY |
2 |
| 171 |
OROPHARYNGEAL PAIN |
2 |
| 172 |
PERIORBITAL SWELLING |
2 |
| 173 |
PRODUCT CONTAMINATION PHYSICAL |
2 |
| 174 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
| 175 |
PRODUCT KNOWLEDGE DEFICIT |
2 |
| 176 |
PRODUCT USE ISSUE |
2 |
| 177 |
RESPIRATORY RATE INCREASED |
2 |
| 178 |
RHINORRHOEA |
2 |
| 179 |
SOMNOLENCE |
2 |
| 180 |
STATUS EPILEPTICUS |
2 |
| 181 |
THERAPEUTIC RESPONSE SHORTENED |
2 |
| 182 |
THERAPY INTERRUPTED |
2 |
| 183 |
THIRST |
2 |
| 184 |
TINNITUS |
2 |
| 185 |
TREATMENT NONCOMPLIANCE |
2 |
| 186 |
TREMOR |
2 |
| 187 |
VISION BLURRED |
2 |
| 188 |
WHEEZING |
2 |
| 189 |
ABDOMINAL DISCOMFORT |
1 |
| 190 |
ABDOMINAL DISTENSION |
1 |
| 191 |
ABDOMINAL MASS |
1 |
| 192 |
ACCIDENTAL OVERDOSE |
1 |
| 193 |
ACNE |
1 |
| 194 |
ACRAL OVERGROWTH |
1 |
| 195 |
ACROCHORDON |
1 |
| 196 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
1 |
| 197 |
ADENOTONSILLECTOMY |
1 |
| 198 |
ADMINISTRATION SITE RASH |
1 |
| 199 |
ADRENOCORTICOTROPIC HORMONE DEFICIENCY |
1 |
| 200 |
AIDS RELATED COMPLEX |
1 |
| 201 |
AMYOTROPHY |
1 |
| 202 |
ANAPHYLACTIC REACTION |
1 |
| 203 |
ANGER |
1 |
| 204 |
APPENDICITIS |
1 |
| 205 |
APPENDICITIS PERFORATED |
1 |
| 206 |
APPLICATION SITE PAIN |
1 |
| 207 |
ARNOLD-CHIARI MALFORMATION |
1 |
| 208 |
ARTERIOSCLEROSIS CORONARY ARTERY |
1 |
| 209 |
ARTHRITIS |
1 |
| 210 |
BITE |
1 |
| 211 |
BLOOD CALCIUM INCREASED |
1 |
| 212 |
BLOOD CREATININE INCREASED |
1 |
| 213 |
BLOOD FOLLICLE STIMULATING HORMONE DECREASED |
1 |
| 214 |
BLOOD GLUCOSE INCREASED |
1 |
| 215 |
BLOOD IMMUNOGLOBULIN A INCREASED |
1 |
| 216 |
BLOOD INSULIN INCREASED |
1 |
| 217 |
BLOOD TEST ABNORMAL |
1 |
| 218 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
| 219 |
BODY TEMPERATURE ABNORMAL |
1 |
| 220 |
BONE DENSITY ABNORMAL |
1 |
| 221 |
BONE PAIN |
1 |
| 222 |
BREAST ENLARGEMENT |
1 |
| 223 |
BREATH ODOUR |
1 |
| 224 |
CARDIAC NEOPLASM UNSPECIFIED |
1 |
| 225 |
CHOLECYSTECTOMY |
1 |
| 226 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR |
1 |
| 227 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
| 228 |
COMA |
1 |
| 229 |
COVID-19 |
1 |
| 230 |
CRITICAL ILLNESS |
1 |
| 231 |
CULTURE POSITIVE |
1 |
| 232 |
CYANOSIS |
1 |
| 233 |
DEHYDRATION |
1 |
| 234 |
DELIRIUM |
1 |
| 235 |
DEPENDENCE ON OXYGEN THERAPY |
1 |
| 236 |
DERMATITIS ALLERGIC |
1 |
| 237 |
DEVICE CONNECTION ISSUE |
1 |
| 238 |
DEVICE LOOSENING |
1 |
| 239 |
DEVICE RELATED INFECTION |
1 |
| 240 |
DEVICE USE CONFUSION |
1 |
| 241 |
DIABETES INSIPIDUS |
1 |
| 242 |
DIPLOPIA |
1 |
| 243 |
DISCOMFORT |
1 |
| 244 |
DISEASE RECURRENCE |
1 |
| 245 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
| 246 |
DRUG INTERACTION |
1 |
| 247 |
DRY EYE |
1 |
| 248 |
DYSKINESIA |
1 |
| 249 |
EAR PAIN |
1 |
| 250 |
EMOTIONAL DISTRESS |
1 |
| 251 |
ENLARGED CLITORIS |
1 |
| 252 |
EOSINOPHIL PERCENTAGE INCREASED |
1 |
| 253 |
EOSINOPHILIA |
1 |
| 254 |
EPHELIDES |
1 |
| 255 |
ERYTHEMA MULTIFORME |
1 |
| 256 |
EXCESSIVE GRANULATION TISSUE |
1 |
| 257 |
EXPOSURE TO CONTAMINATED DEVICE |
1 |
| 258 |
EXPOSURE VIA EYE CONTACT |
1 |
| 259 |
EXTREMITY CONTRACTURE |
1 |
| 260 |
FACE OEDEMA |
1 |
| 261 |
FEELING HOT |
1 |
| 262 |
FLUSHING |
1 |
| 263 |
FOCAL PERITONITIS |
1 |
| 264 |
FOREIGN BODY IN SKIN OR SUBCUTANEOUS TISSUE |
1 |
| 265 |
FRACTURE |
1 |
| 266 |
FUNGAL INFECTION |
1 |
| 267 |
GAIT INABILITY |
1 |
| 268 |
GALLBLADDER OPERATION |
1 |
| 269 |
GASTRIC INFECTION |
1 |
| 270 |
GASTROINTESTINAL DISORDER |
1 |
| 271 |
GASTROINTESTINAL INFECTION |
1 |
| 272 |
GOITRE |
1 |
| 273 |
GREY MATTER HETEROTOPIA |
1 |
| 274 |
GROWTH FAILURE |
1 |
| 275 |
HAEMATEMESIS |
1 |
| 276 |
HAEMATURIA |
1 |
| 277 |
HAEMOGLOBINURIA |
1 |
| 278 |
HAEMORRHAGE |
1 |
| 279 |
HAIR GROWTH ABNORMAL |
1 |
| 280 |
HAND-FOOT-AND-MOUTH DISEASE |
1 |
| 281 |
HEAD BANGING |
1 |
| 282 |
HEART RATE ABNORMAL |
1 |
| 283 |
HEART RATE DECREASED |
1 |
| 284 |
HEAT EXHAUSTION |
1 |
| 285 |
HYPERINSULINAEMIA |
1 |
| 286 |
HYPERTHERMIA |
1 |
| 287 |
HYPERTHYROIDISM |
1 |
| 288 |
HYPOPITUITARISM |
1 |
| 289 |
HYPOTHYROIDISM |
1 |
| 290 |
HYPOTONIA |
1 |
| 291 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
1 |
| 292 |
IMPAIRED GASTRIC EMPTYING |
1 |
| 293 |
INCORRECT DOSE ADMINISTERED BY PRODUCT |
1 |
| 294 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
| 295 |
INFECTION |
1 |
| 296 |
INFLAMMATION |
1 |
| 297 |
INFREQUENT BOWEL MOVEMENTS |
1 |
| 298 |
INFUSION RELATED REACTION |
1 |
| 299 |
INFUSION SITE BRUISING |
1 |
| 300 |
INFUSION SITE DISCHARGE |
1 |
| 301 |
INFUSION SITE IRRITATION |
1 |
| 302 |
INFUSION SITE OEDEMA |
1 |
| 303 |
INFUSION SITE PAIN |
1 |
| 304 |
INITIAL INSOMNIA |
1 |
| 305 |
INJECTION SITE DISCOLOURATION |
1 |
| 306 |
INJECTION SITE EXFOLIATION |
1 |
| 307 |
INJECTION SITE HYPERTROPHY |
1 |
| 308 |
INJECTION SITE PARAESTHESIA |
1 |
| 309 |
INJECTION SITE SCAR |
1 |
| 310 |
INJECTION SITE VESICLES |
1 |
| 311 |
INJECTION SITE WARMTH |
1 |
| 312 |
INSULIN RESISTANT DIABETES |
1 |
| 313 |
INSURANCE ISSUE |
1 |
| 314 |
INTENTIONAL DOSE OMISSION |
1 |
| 315 |
INTESTINAL RESECTION |
1 |
| 316 |
IRRITABILITY |
1 |
| 317 |
JOINT INJURY |
1 |
| 318 |
JOINT INSTABILITY |
1 |
| 319 |
JOINT RANGE OF MOTION DECREASED |
1 |
| 320 |
KETOSIS |
1 |
| 321 |
KIDNEY SMALL |
1 |
| 322 |
KNEE OPERATION |
1 |
| 323 |
LACK OF ADMINISTRATION SITE ROTATION |
1 |
| 324 |
LACRIMATION INCREASED |
1 |
| 325 |
LARYNGEAL STENOSIS |
1 |
| 326 |
LETHARGY |
1 |
| 327 |
LEUKAEMIA |
1 |
| 328 |
LEUKOPENIA |
1 |
| 329 |
LIMB ASYMMETRY |
1 |
| 330 |
LIMB MASS |
1 |
| 331 |
LIPOATROPHY |
1 |
| 332 |
LIPOMA |
1 |
| 333 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
| 334 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
| 335 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
| 336 |
MACULE |
1 |
| 337 |
MALNUTRITION |
1 |
| 338 |
MAMMOGRAM ABNORMAL |
1 |
| 339 |
MASS |
1 |
| 340 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
| 341 |
MEAN CELL HAEMOGLOBIN DECREASED |
1 |
| 342 |
MEAN PLATELET VOLUME INCREASED |
1 |
| 343 |
MEDICAL DEVICE DISCOMFORT |
1 |
| 344 |
MEDICAL DEVICE SITE DISCHARGE |
1 |
| 345 |
MEDICAL DEVICE SITE INFECTION |
1 |
| 346 |
MENINGITIS |
1 |
| 347 |
MENTAL IMPAIRMENT |
1 |
| 348 |
METASTASES TO BONE MARROW |
1 |
| 349 |
MILIARIA |
1 |
| 350 |
MOBILITY DECREASED |
1 |
| 351 |
MONOCYTE PERCENTAGE INCREASED |
1 |
| 352 |
MOOD SWINGS |
1 |
| 353 |
MORAXELLA INFECTION |
1 |
| 354 |
MOUTH HAEMORRHAGE |
1 |
| 355 |
MUSCLE HYPERTROPHY |
1 |
| 356 |
MUSCLE INJURY |
1 |
| 357 |
MUSCLE SPASMS |
1 |
| 358 |
MUSCLE TWITCHING |
1 |
| 359 |
MUSCULAR WEAKNESS |
1 |
| 360 |
MUSCULOSKELETAL STIFFNESS |
1 |
| 361 |
MYALGIA |
1 |
| 362 |
MYDRIASIS |
1 |
| 363 |
MYOCARDIAL INFARCTION |
1 |
| 364 |
MYOCLONUS |
1 |
| 365 |
MYOPIA |
1 |
| 366 |
NAEVUS HAEMORRHAGE |
1 |
| 367 |
NASAL DISCHARGE DISCOLOURATION |
1 |
| 368 |
NASAL POLYPS |
1 |
| 369 |
NECK PAIN |
1 |
| 370 |
NEPHROTIC SYNDROME |
1 |
| 371 |
NERVOUSNESS |
1 |
| 372 |
NEUROBLASTOMA RECURRENT |
1 |
| 373 |
NEUROLOGICAL EXAMINATION ABNORMAL |
1 |
| 374 |
NEUTROPENIA |
1 |
| 375 |
NEUTROPHIL COUNT DECREASED |
1 |
| 376 |
NEUTROPHIL PERCENTAGE DECREASED |
1 |
| 377 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
1 |
| 378 |
OPHTHALMOLOGICAL EXAMINATION ABNORMAL |
1 |
| 379 |
OROPHARYNGEAL DISCOMFORT |
1 |
| 380 |
ORTHOSTATIC HYPOTENSION |
1 |
| 381 |
OVERDOSE |
1 |
| 382 |
PALLOR |
1 |
| 383 |
PANCREATITIS |
1 |
| 384 |
PARTIAL SEIZURES |
1 |
| 385 |
PETECHIAE |
1 |
| 386 |
PETIT MAL EPILEPSY |
1 |
| 387 |
PHARYNGEAL INFLAMMATION |
1 |
| 388 |
PHARYNGEAL SWELLING |
1 |
| 389 |
PHOTOSENSITIVITY REACTION |
1 |
| 390 |
PINEAL GLAND CYST |
1 |
| 391 |
PITUITARY STALK INTERRUPTION SYNDROME |
1 |
| 392 |
PNEUMOCOCCAL INFECTION |
1 |
| 393 |
PNEUMONIA MYCOPLASMAL |
1 |
| 394 |
PNEUMONIA PNEUMOCOCCAL |
1 |
| 395 |
PNEUMONIA STAPHYLOCOCCAL |
1 |
| 396 |
PNEUMONIA VIRAL |
1 |
| 397 |
POLYURIA |
1 |
| 398 |
PRECOCIOUS PUBERTY |
1 |
| 399 |
PRESCRIBED UNDERDOSE |
1 |
| 400 |
PRESYNCOPE |
1 |
| 401 |
PRODUCT ADMINISTRATION ERROR |
1 |
| 402 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
| 403 |
PRODUCT COMPLAINT |
1 |
| 404 |
PRODUCT LEAKAGE |
1 |
| 405 |
PRODUCT NAME CONFUSION |
1 |
| 406 |
PRODUCT SELECTION ERROR |
1 |
| 407 |
PRODUCT STORAGE ERROR |
1 |
| 408 |
PRODUCT SUBSTITUTION ISSUE |
1 |
| 409 |
PRODUCTIVE COUGH |
1 |
| 410 |
PROTEIN-LOSING GASTROENTEROPATHY |
1 |
| 411 |
PSEUDOMONAS INFECTION |
1 |
| 412 |
PSYCHOLOGICAL TRAUMA |
1 |
| 413 |
PYELONEPHRITIS |
1 |
| 414 |
RASH ERYTHEMATOUS |
1 |
| 415 |
RASH PRURITIC |
1 |
| 416 |
REACTION TO PRESERVATIVES |
1 |
| 417 |
RECTAL FISSURE |
1 |
| 418 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
| 419 |
RENAL ATROPHY |
1 |
| 420 |
RENAL FAILURE |
1 |
| 421 |
RENAL IMPAIRMENT |
1 |
| 422 |
RESPIRATORY TRACT INFECTION |
1 |
| 423 |
RHINOVIRUS INFECTION |
1 |
| 424 |
SEPSIS |
1 |
| 425 |
SEPTIC SHOCK |
1 |
| 426 |
SEPTO-OPTIC DYSPLASIA |
1 |
| 427 |
SHORT STATURE |
1 |
| 428 |
SINUS DISORDER |
1 |
| 429 |
SKIN DISORDER |
1 |
| 430 |
SKIN HYPERPIGMENTATION |
1 |
| 431 |
SKIN LESION |
1 |
| 432 |
SLEEP APNOEA SYNDROME |
1 |
| 433 |
SLEEP DISORDER |
1 |
| 434 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
| 435 |
SNEEZING |
1 |
| 436 |
SPINAL CORD OEDEMA |
1 |
| 437 |
SPONTANEOUS HAEMATOMA |
1 |
| 438 |
STAPHYLOCOCCAL INFECTION |
1 |
| 439 |
STREPTOCOCCAL INFECTION |
1 |
| 440 |
SUICIDAL BEHAVIOUR |
1 |
| 441 |
SUICIDAL IDEATION |
1 |
| 442 |
SUSPECTED COVID-19 |
1 |
| 443 |
SUSPECTED OFF LABEL USE |
1 |
| 444 |
SWELLING FACE |
1 |
| 445 |
SYRINGE ISSUE |
1 |
| 446 |
SYRINGOMYELIA |
1 |
| 447 |
TEARFULNESS |
1 |
| 448 |
TENSION |
1 |
| 449 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
| 450 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
| 451 |
THERAPY CESSATION |
1 |
| 452 |
THYROID DISORDER |
1 |
| 453 |
THYROXINE INCREASED |
1 |
| 454 |
TONSILLAR HYPERTROPHY |
1 |
| 455 |
TURNER^S SYNDROME |
1 |
| 456 |
TYPE 1 DIABETES MELLITUS |
1 |
| 457 |
UPPER LIMB FRACTURE |
1 |
| 458 |
UPPER RESPIRATORY TRACT CONGESTION |
1 |
| 459 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
| 460 |
URETHRAL OPERATION |
1 |
| 461 |
URINARY TRACT INFECTION |
1 |
| 462 |
VASCULAR DEVICE INFECTION |
1 |
| 463 |
VASCULAR INJURY |
1 |
| 464 |
VEIN RUPTURE |
1 |
| 465 |
VERTIGO |
1 |
| 466 |
VITREOUS FLOATERS |
1 |
| 467 |
WEIGHT LOSS POOR |
1 |
| 468 |
WOUND INFECTION STAPHYLOCOCCAL |
1 |
| 469 |
WRONG DOSE |
1 |
| 470 |
WRONG PRODUCT ADMINISTERED |
1 |